Nosocomial infection are estimated to involve more than 2 million patients
annually and in 1992 cost more than $4,5 billion in the USA (1).
The surfaces of indwelling medical devices are an excellent platform for th
e formation of life-threatening infections. Although aseptic techniques can
reduce the incidence of these infections, a significant risk remains. The
coupling or incorporation of antimicrobial substances to or into catheter m
aterials may be a suitable way to prevent the development of catheter assoc
iated infections as suggested by in vitro and in vivo studies. Various surf
ace treatments are emerging as important. Early efforts that concentrated o
n adsorption of antibiotics to device surfaces achieved limited results as
shown in several clinical studies. The promising approach features the inco
rporation of antimicrobial drugs into the polymer matrices that entrap but
do not bind the drugs, allowing for extended release. Incorporation of anti
microbials in the bulk material that constitutes a device can be effective
as shown in several in vitro and in vivo studies. In future, modification o
f both short-term and long term catheters by biofilm-active antimicrobials
creating slow delivery systems may provide an effective method to protect p
atients from nosocomial infection.